|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.910 NZD | 0.00% |
|
+5.68% | +15.68% |
| 07-07 | AFT Pharmaceuticals On Track to Achieve Fiscal 2027 Revenue Target; Iron Injectable Product Clears Regulatory Hurdles | MT |
| 06-24 | NZX Biggest Gainers | MT |
| Market Cap | 410M 237M 207M 191M 176M 335M 22.57B 340M 2.28B 896M 11.12B 888M 869M 38.22B | P/E 2027 * |
20.8x | P/E 2028 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 440M 254M 222M 205M 189M 359M 24.21B 365M 2.45B 961M 11.93B 953M 932M 41B | EV / Sales 2027 * |
1.45x | EV / Sales 2028 * | 1.26x |
| Free-Float |
22.37% | Yield 2027 * |
0.84% | Yield 2028 * | 1.06% |
Last Transcript: AFT Pharmaceuticals Limited
| 20/01/24 | Rentevrees zet Bel20 onder druk | |
| 19/01/24 | KBC uitblinker op groene beurs | |
| 19/01/24 | Brusselse beurs opent flink hoger | |
| 19/01/24 | Brussel start handelsdag vermoedelijk in het groen | |
| 18/01/24 | Hyloris gaat samenwerken met AFT Pharmaceuticals |
| 1 week | +5.68% | ||
| Current month | +6.83% | ||
| 1 month | -0.76% | ||
| 3 months | +6.25% | ||
| 6 months | +12.36% | ||
| Current year | +15.68% |
| 1 week | 3.71 |  | 4 |
| 1 month | 3.65 | | 4 |
| Current year | 3.35 | | 4 |
| 1 year | 2.54 | | 4 |
| 3 years | 2.37 | | 4 |
| 5 years | 2.37 | | 5 |
| 10 years | 1.7 | | 5.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marree Atkinson
HRO | Human Resources Officer | - | 03/09/2012 |
Hartley Atkinson
CEO | Chief Executive Officer | - | 03/09/1997 |
Stuart Houliston
DFI | Director of Finance/CFO | - | 14/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
David Flacks
CHM | Chairman | - | 21/06/2015 |
Hartley Atkinson
BRD | Director/Board Member | - | 03/09/1997 |
Marree Atkinson
BRD | Director/Board Member | - | 03/09/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/07/25 | Buy | Founder | 200,000 | 0.1907% | ||
| 25/06/25 | Free | Founder | 17,755 | 0.0169% | ||
| 01/12/24 | Buy | Founder | 45 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +5.68% | +46.99% | +5.11% | 237M | |
| -2.33% | -2.09% | +50.33% | +162.29% | 1,060B | |
| -0.82% | -2.30% | +62.97% | +61.11% | 619B | |
| -0.73% | -4.98% | +27.22% | +84.46% | 438B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 333B | |
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 267B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 218B | |
| -0.06% | -2.88% | +20.98% | +61.70% | 196B | |
| -3.72% | -1.10% | +13.35% | +71.53% | 161B | |
| Average | -0.80% | -2.35% | +26.66% | +50.47% | 357.41B | |
| Weighted average by Cap. | -0.56% | -2.96% | +35.28% | +81.26% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304M 175M 153M 141M 131M 248M 16.72B 252M 1.69B 664M 8.24B 658M 644M 28.32B | 345M 199M 174M 161M 148M 282M 19B 286M 1.92B 754M 9.36B 748M 732M 32.19B |
| Net income | 19.71M 11.37M 9.95M 9.18M 8.47M 16.08M 1.08B 16.35M 110M 43.05M 534M 42.7M 41.77M 1.84B | 24.84M 14.33M 12.54M 11.56M 10.68M 20.26M 1.37B 20.61M 138M 54.26M 673M 53.81M 52.64M 2.31B |
| Net Debt | 29.84M 17.22M 15.06M 13.89M 12.83M 24.35M 1.64B 24.75M 166M 65.18M 809M 64.65M 63.24M 2.78B | 24.59M 14.19M 12.41M 11.45M 10.57M 20.06M 1.35B 20.4M 137M 53.71M 667M 53.27M 52.11M 2.29B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | NZ$3.910 | 0.00% | 65,764 |
| 08/07/26 | NZ$3.910 | +0.51% | 17,313 |
| 07/07/26 | NZ$3.890 | +4.85% | 26,498 |
| 06/07/26 | NZ$3.710 | +0.27% | 10,511 |
| 03/07/26 | NZ$3.700 | +0.82% | 3,160 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AFT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
